Improving outcomes and accelerating treatments through data-driven, remote, proactive care

Sandra Abrevaya

December 6, 2022

Sandra Abrevaya
October 19, 2022

Ready to get started?

Enroll now for a free call with our Care Coordinators

Learn moreRegister Now

Continue reading

ALS: The Disease that Stopped “The Iron Horse,” Lou Gehrig
October 19, 2022
On June 2nd, MLB honors Lou Gehrig to raise awareness about ALS
Meet Our Team: Q&A with Synapticure’s Prior Authorization Expert
May 31, 2023
Devin Scott, Synapticure’s expert in prior authorizations and medication approvals, discusses tricks of the trade and why he’s passionate about supporting our patients
What’s the “joint” data between Parkinson’s disease and Rheumatoid Arthritis?
November 9, 2022
In honor of Autoimmune Arthritis Day, we explore the growing literature about the association between Parkinson’s disease and Rheumatoid Arthritis
ALS
PLS
Parkinson's Disease

More from our blog

View all ›

ALS: The Disease that Stopped “The Iron Horse,” Lou Gehrig

Peter Wallach

June 2, 2023

Helping You Access Amylyx's New Drug

Danielle Geraldi-Samara, MD

June 2, 2023

What does it cost to see a Synapticure MD in-network?

Sandra Abrevaya

June 2, 2023

It is time to leave behind the era of

“I’m sorry but we can’t help you.”

Get Started
Ph: +1 708-630-1534
Fax: +1 888-517-8619

2045 W Grand Ave Ste B Chicago, IL 60612

Navigation
ALSPLSParkinson's DiseaseCliniciansInsurance Coverage
FAQ
Patient QuestionsPresymptomatic IRB
About us
BlogTeamCareersCollaboratorsPressContact
Legal
Privacy PolicyTerms of ServiceNotice of Privacy PracticesTelehealth Informed ConsentFCOI

This office appreciates the diversity of human beings and does not discriminate based on race, age, religion, ability,  marital status, sexual orientation, sex or gender identity.

© Copyright Synapticure. All rights reserved.